此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Venous Return Pressure Gradient as a Predictor of Acute Kidney Injury (VRPG-AKI)

2026年7月22日 更新者:Rongan Liu、Sichuan Academy of Medical Sciences

Venous Return Pressure Gradient Predicts Acute Kidney Injury Onset and Progression

Acute kidney injury (AKI) is a common and serious complication in the ICU. Current diagnostic indicators (such as creatinine and urine output) exhibit significant lag, and specific hemodynamic predictive markers are lacking. The venous return pressure gradient (Pmsf-CVP), based on Guyton's theory, reflects the driving pressure for venous return; however, its value in the early warning of AKI remains unclear. This study aims to investigate the predictive value of the venous return pressure gradient for the onset and progression of AKI in ICU patients, and to clarify its effectiveness as an AKI risk warning indicator.

Patients admitted to the ICU within 48 hours with risk factors for AKI (including sepsis, shock, major surgery, underlying diseases, etc.) who have radial artery catheterization and can undergo hemodynamic monitoring will be enrolled. Those undergoing maintenance dialysis/CRRT, ECMO support, or with missing core data precluding calculation of Pmsf-CVP or AKI assessment will be excluded.

The venous return pressure gradient (Pmsf-CVP, mmHg) will be measured within 48 hours of ICU admission using the transient stop-flow arm arterial-venous equilibrium pressure method. The primary outcome is to evaluate the association between the venous return pressure gradient level and AKI occurrence. Secondary outcomes include correlation analyses between the venous return pressure gradient level and serum creatinine and urine output within 48 hours of ICU admission, among others.

研究概览

地位

尚未招聘

研究类型

观察性的

注册 (估计的)

180

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

  • 姓名:rongan Liu
  • 电话号码:+8615928731511
  • 邮箱:35279240@qq.com

研究联系人备份

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

取样方法

非概率样本

研究人群

Adult ICU patients (age ≥18 years) at risk for acute kidney injury, with central venous and radial arterial catheters in place for hemodynamic monitoring, no AKI at ICU admission per KDIGO criteria, and complete data available for calculation of venous return pressure gradient (Pmsf-CVP) within 48 hours of admission.

描述

Inclusion Criteria:

  1. Age ≥18 years
  2. Admitted to the intensive care unit (ICU) within 48 hours
  3. Central venous catheter in place for continuous central venous pressure (CVP) monitoring
  4. Radial artery catheter in place for hemodynamic monitoring including mean systemic filling pressure (Pmsf)
  5. No acute kidney injury (AKI) at ICU admission according to KDIGO criteria

Exclusion Criteria:

  1. Maintenance hemodialysis or continuous renal replacement therapy (CRRT) prior to ICU admission
  2. Previous kidney transplantation
  3. Pregnancy
  4. Extracorporeal membrane oxygenation (ECMO) support at ICU admission
  5. Incomplete core hemodynamic data precluding calculation of venous return pressure gradient (Pmsf-CVP) or AKI assessment

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Acute Kidney Injury occurrence
大体时间:Within 48 hours of ICU admission
Occurrence of acute kidney injury diagnosed according to KDIGO criteria (serum creatinine increase ≥1.5 times baseline, or ≥26 μmol/L within 48 hours, or urine output <0.5 mL/kg/h for ≥6 hours) during the ICU stay. The association between venous return pressure gradient (Pmsf-CVP, measured within the first 48 hours of ICU admission using the Pmsf-arm method) and AKI occurrence will be assessed by multivariable logistic regression analysis, adjusting for APACHE II score, baseline serum creatinine, lactate, mean arterial pressure, sepsis, and shock.
Within 48 hours of ICU admission

次要结果测量

结果测量
措施说明
大体时间
Persistent Acute Kidney Injury
大体时间:Within 48 hours after AKI occurrence during the ICU stay
Persistent AKI defined as failure of renal function to return to baseline within 48 hours after AKI occurrence during the ICU stay. The predictive value of venous return pressure gradient (Pmsf-CVP) for persistent AKI will be evaluated by ROC curve analysis.
Within 48 hours after AKI occurrence during the ICU stay
AKI severity grade
大体时间:At the time of maximum AKI stage during the ICU stay, up to 28 days
Maximum AKI stage (KDIGO stage 1, 2, or 3) achieved during the ICU stay.
At the time of maximum AKI stage during the ICU stay, up to 28 days
In-hospital mortality
大体时间:From ICU admission to hospital discharge, up to 90 days
All-cause mortality during the index hospitalization.
From ICU admission to hospital discharge, up to 90 days
Total length of hospital stay
大体时间:From hospital admission to discharge or death, up to 90 days
Number of days from hospital admission to hospital discharge or in-hospital death, whichever comes first. Patients still hospitalized at day 90 will be censored at 90 days.
From hospital admission to discharge or death, up to 90 days
Correlation between venous return pressure gradient and serum creatinine
大体时间:Within 48 hours of ICU admission
Spearman rank correlation analysis between Pmsf-CVP (measured within 48 hours of ICU admission) and serum creatinine levels (baseline creatinine at ICU admission and peak creatinine during ICU stay).
Within 48 hours of ICU admission
Correlation between venous return pressure gradient and lactate
大体时间:Within 48 hours of ICU admission
Spearman rank correlation analysis between Pmsf-CVP (measured within 48 hours of ICU admission) and lactate levels obtained from the first arterial blood gas analysis within 48 hours of ICU admission.
Within 48 hours of ICU admission
Duration of mechanical ventilation
大体时间:From intubation to first successful extubation
Number of days on invasive mechanical ventilation from the time of first intubation to the first successful extubation. Reintubation within 48 hours will be counted as continuous ventilation.
From intubation to first successful extubation
Length of ICU stay
大体时间:From ICU admission to ICU discharge
Number of days from ICU admission to ICU discharge.
From ICU admission to ICU discharge

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年7月5日

初级完成 (估计的)

2027年5月1日

研究完成 (估计的)

2027年5月1日

研究注册日期

首次提交

2026年6月30日

首先提交符合 QC 标准的

2026年7月22日

首次发布 (实际的)

2026年7月23日

研究记录更新

最后更新发布 (实际的)

2026年7月23日

上次提交的符合 QC 标准的更新

2026年7月22日

最后验证

2026年7月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅